7 July 2021
At the meeting of 9 June 2021 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| familial adenomatous polyposis | 77/2021 | 78/2021 |
| solar keratosis | 79/2021 | 80/2021 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined Amendment Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| hypopituitarism | 81/2021 | 82/2021 |
| diabetes mellitus | 83/2021 | 84/2021 |
The above SOPs take effect from 26 July 2021.
Summary of Changes
Completed Investigations
The above determinations conclude the previously advertised investigations into:
- familial adenomatous polyposis
- solar keratosis
- hypopituitarism (focussed review - definition)
- diabetes mellitus (focussed review - infection with Coxsackie B virus)
- diabetes mellitus (focussed review - immune checkpoint inhibitors and interferon)
New Investigations
Decided to advertise the following investigations:
- thoracic outlet syndrome
- gender dysphoria
- sensorineural hearing loss (focussed review - xylene)
The above investigation notices appear in the Government Notices Gazette of 6 July 2021.